A Validation and Dosimetry Study of GSK2634673F PET Ligand

NCT02052297 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to challenges recruiting subjects with fibrotic interstitial lung disease associated with a connective tissue disease for Part D

Conditions

Interventions

Sponsor

GlaxoSmithKline